Omada Health, Inc. Revenue
Omada Health, Inc. (OMDA) reported Revenue of $87.83 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-07
- Omada Health, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $87.83M, a 43.12% increase year-over-year.
- Omada Health, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $78.05M, a 42.00% increase year-over-year.
- Omada Health, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $75.85M, a 58.08% increase year-over-year.
- Omada Health, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $68.03M, a 49.47% increase year-over-year.
- Omada Health, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $260.21M, a 53.24% increase from fiscal 2024.
- Omada Health, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $169.80M, a 38.29% increase from fiscal 2023.
- Omada Health, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $122.78M.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $87.83M 10-Q · filed 2026-08-07 | $165.88M 10-Q · filed 2026-08-07 | $241.73M derived: sum of 3 quarters · filed 2026-08-07 | $309.76M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $78.05M 10-Q · filed 2026-05-08 | $153.89M derived: sum of 2 quarters · filed 2026-05-08 | $221.92M derived: sum of 3 quarters · filed 2026-05-08 | $283.30M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $75.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $143.88M derived: sum of 2 quarters · filed 2026-03-06 | $205.25M derived: sum of 3 quarters · filed 2026-08-07 | $260.21M 10-K · filed 2026-03-06 |
| 2025-09-30 | $68.03M 10-Q · filed 2025-11-07 | $129.40M derived: sum of 2 quarters · filed 2026-08-07 | $184.36M 10-Q · filed 2025-11-07 | $232.34M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $61.37M 10-Q · filed 2026-08-07 | $116.33M 10-Q · filed 2026-08-07 | $164.31M derived: sum of 3 quarters · filed 2026-08-07 | $209.83M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $54.96M 10-Q · filed 2026-05-08 | $102.94M derived: sum of 2 quarters · filed 2026-05-08 | $148.46M derived: sum of 3 quarters · filed 2026-05-08 | $189.67M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $47.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $93.49M derived: sum of 2 quarters · filed 2026-03-06 | $134.71M derived: sum of 3 quarters · filed 2026-03-06 | $169.80M 10-K · filed 2026-03-06 |
| 2024-09-30 | $45.52M 10-Q · filed 2025-11-07 | $86.73M derived: sum of 2 quarters · filed 2025-11-07 | $121.82M 10-Q · filed 2025-11-07 | |
| 2024-06-30 | $41.21M 10-Q · filed 2025-08-08 | $76.31M 10-Q · filed 2025-08-08 | ||
| 2023-12-31 | $122.78M 10-K · filed 2026-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |